Treating pain associated with chemotherapy-induced peripheral neuropathy
AssigneeMedicon Pharmaceuticals, Inc.
InventorBasil RIGAS
Life of this patent
Estimating the term…
Abstract
The invention features methods of preventing and/or treating neuropathic pain associated with chemotherapy-induced peripheral neuropathy (CIPN).
Claims60
A method of treating and/or preventing neuropathic pain associated with chemotherapy induced peripheral neuropathy (CIPN) comprising administering a therapeutically effective amount of phosphosulindac (PS) to a subject in need thereof such that neuropathic pain associated with CIPN is treated and/or prevented.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.